Skip to content

Active substances

Gentamicin

Author: Markus Falkenstätter, BScReviewed by Mag. pharm. Stefanie Brandauer (Pharmacist)
Contents
  1. Basics
  2. Pharmacology
  3. Toxicity

Advertisement

Basics

Gentamicin is an antibiotic from the group of aminoglycosides that is used to treat various types of bacterial infections. It is a mixture of substances consisting of several antibacterial compounds. These include bone infections, endocarditis, pelvic inflammatory disease, meningitis, pneumonia, urinary tract infections, and blood poisoning (sepsis). It is ineffective against gonorrhea or chlamydial infections. It can be given intravenously, by injection into a muscle, or topically. Topical formulations may be used for burns or eye infections.

Pharmacology

Pharmacodynamics

Gentamicin is a bactericidal antibiotic that acts by binding to the 30S subunit of the bacterial ribosome, thereby interfering with protein synthesis. Gentamicin's binding to the ribosome prevents bacterial tRNA from fully binding to the ribosome, resulting in protein chain termination. This inhibits the growth and multiplication of the bacteria.

Pharmacokinetics

The oral bioavailability of gentamicin is too low for peroral administration. Therefore, gentamicin is used exclusively parenterally (injection) or on the skin. Protein binding is 0-30%. The half-life is about 3-5 hours.

Toxicity

Side effects

  • low blood cell counts
  • Allergic reactions
  • Neuromuscular problems
  • nerve damage (neuropathy)
  • Kidney damage (nephrotoxicity)
  • ear problems (ototoxicity)

Gentamicin can cause inner ear problems and kidney problems. The inner ear problems can cause problems with balance and hearing loss. Nephrotoxicity and ototoxicity are dose-dependent, with higher doses bringing a greater risk of side effects. These side effects may continue to occur even after gentamicin is stopped.

If used during pregnancy, it may harm the developing baby. However, use during breastfeeding is considered safe.

Toxicological data

LD50 (rat, oral): >5000 mg sulfate-kg-1

Markus Falkenstätter, BSc

Author

Markus Falkenstätter, BSc

Pharmacy student

Markus Falkenstätter is a writer on pharmaceutical topics in Medikamio's medical editorial team. He is in the last semester of his pharmacy studies at the University of Vienna and loves scientific work in the field of natural sciences.

Mag. pharm. Stefanie Brandauer

Reviewer

Mag. pharm. Stefanie Brandauer

Pharmacist

Stefanie Lehenauer has been a freelance writer for Medikamio since 2020 and studied pharmacy at the University of Vienna. She works as a pharmacist in Vienna and her passion is herbal medicines and their effects.


Editorial principles

All information used for our content comes from verified sources (recognised institutions, specialists, studies by renowned universities). We place great value on the qualification of the authors and the scientific background of the information, so that our research is based on scientific evidence.

medikamio

Your personal medication assistant

The presented content does not replace the original package insert of the medication, especially regarding the dosage and effects of individual products. We cannot assume liability for the accuracy of the data, as the data has been partially converted automatically. Always consult a doctor for diagnoses and other health-related questions.

© 2026 medikamio